Evidence map›Paper›PMID 40227807›Full record

ArticleCancers2025

HPV-Related Knowledge and Impact of Patient-Provider Communication on HPV-Associated Cervical Cancer Awareness and Pap Smear Completion in US Women Aged 21-65 Years.

Adrienne Dean, Nada Eldawy, Jennifer Mendonca, Diana Lobaina, Yasmine Zerrouki, Goodness Okwaraji, Vama Jhumkhawala, Sara Burgoa, Chinenye Lynette Ejezie, Panagiota Kitsantas and 2 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adrienne DeanCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0002-5507-8185
Nada EldawyCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0009-0008-3776-9709
Jennifer MendoncaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
Diana LobainaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0003-0623-7650
Yasmine ZerroukiCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
Goodness OkwarajiCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0009-0005-1845-390X
Vama JhumkhawalaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0002-1001-3089
Sara BurgoaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0009-0007-5392-3676
Chinenye Lynette EjezieDepartment of Health Sciences, Towson University, Towson, MD 21252, USA.
Panagiota KitsantasCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
Maria MejiaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0003-0703-8688
Lea SaccaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0002-0629-2863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe United States (US) continues to face a substantial burden of cervical cancer, which has been the focus of many policies and public health prevention agendas. Of the numerous risk factors associated with cervical cancer, human papillomavirus (HPV) infection remains the leading and most preventable cause of this chronic disease. Therefore, one major public health prevention strategy to decrease cervical cancer cases is HPV vaccination. Another screening tool that enables cervical cancer prevention and early intervention is the Pap smear, the primary method of screening for abnormal cervical cells. However, barriers such as social determinants of health and ineffective patient-provider communication hinder access to such critical preventive measures. The purpose of this study was to provide a comprehensive overview of the knowledge level of US female adults, aged 21-65 years, concerning HPV infection and cervical cancer prevention using the Health Information National Trends Survey (HINTS) database. Additionally, it assessed associations between patient-provider communication and the completion of Pap smear tests.

methodsDescriptive statistics were computed to explore the sociodemographic characteristics of female survey participants as well as to gather frequency and percentages of responses related to knowledge of HPV, awareness of the HPV vaccine, and history of Pap smear. Chi-squared tests were carried out to examine the associations between awareness of a cervical cancer vaccine or HPV shot and whether the participant has had a Pap smear, heard of the HPV vaccine, and knowledge of HPV's association with cervical cancer. Next, binary logistic regression models were built to determine the size and direction of the association between patient-provider communication metrics and measures of (1) having had a Pap smear, (2) participant knowledge of HPV, (3) participant awareness of causality between HPV and cervical cancer, and (4) participant knowledge of HPV vaccine and cervical cancer prevention measures.

resultsA substantial majority of participants (81.8%) reported having heard of HPV. Among them, 72.1% recognized that HPV could cause cervical cancer. Awareness of the HPV vaccine was reported by 88.1%, suggesting a relatively high reach of effective public health messaging. Regarding Pap tests, 43.3% of participants had undergone testing within the past year, but 12.6% had not been tested in over five years, and 3.6% have never been tested. Bivariate analysis using chi-squared tests revealed significant associations between participants' history of Pap smears and their knowledge of HPV infection, its role in cervical cancer, and HPV vaccination as a prevention tool. Participants who had undergone a Pap test were more likely to have heard of HPV (

conclusionsStrengthening provider communication and education skills not only encourages greater patient knowledge and adherence to preventative measures, such as HPV and cervical cancer screening, but also reduces disparities in healthcare stemming from limited health literacy.

Indexed as

cervical cancer screeningHPV vaccinationPap smearspatient–provider communicationsocial determinants of health

Identifiers

PMID40227807
PMCPMC11987755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.